4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0001209191-23-021443
Chief Executive Officer sold 5,912 shares at $16.00 ($94,592)
- Chief Executive Officer acquired 5,912 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harris Todd Chief Executive Officer | 2023-03-24 | Option exercise | +170 | $2.25 | $383 | 1,701,446 | D: show line 1 in the form |
| Harris Todd Chief Executive Officer | 2023-03-24 | Sale | −170 | $16.00 | $2,720 | 1,701,276 | D: show line 2 in the form |
| Harris Todd Chief Executive Officer | 2023-03-27 | Option exercise | +2,963 | $2.25 | $6,667 | 1,704,239 | D: show line 3 in the form |
| Harris Todd Chief Executive Officer | 2023-03-27 | Sale | −2,963 | $16.00 | $47,408 | 1,701,276 | D: show line 4 in the form |
| Harris Todd Chief Executive Officer | 2023-03-28 | Option exercise | +2,779 | $2.25 | $6,253 | 1,704,055 | D: show line 5 in the form |
| Harris Todd Chief Executive Officer | 2023-03-28 | Sale | −2,779 | $16.00 | $44,464 | 1,701,276 | D: show line 6 in the form |
| Open-market sales · 5,912 sh · avg $16.00 · $94,592 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harris Todd Chief Executive Officer | 2023-03-24 | Option exercise · Stock Option (Right to Buy) | −170 | 409,606 | D: show line 7 in the form | ||
| Harris Todd Chief Executive Officer | 2023-03-27 | Option exercise · Stock Option (Right to Buy) | −2,963 | 406,643 | D: show line 8 in the form | ||
| Harris Todd Chief Executive Officer | 2023-03-28 | Option exercise · Stock Option (Right to Buy) | −2,779 | 403,864 | D: show line 9 in the form |
Loading xslF345X04/doc4.xml…